OVERVIEW: This funder is passionate about disease funding, and has a wide range of research interests, from rare genetic conditions to cardiovascular diseases, cancer, and more. It has a global funding reach and donates millions of dollars each year, as well as products and skills.
IP TAKE: Sanofi Genzyme is a very approachable funder that accepts applications year round and supports research into a wide variety of diseases.
PROFILE: Sanofi Genzyme (a fully owned subsidiary of Sanofi) was founded in Boston in 1981, and has become one of the largest biotech companies in the world. The company is located in Cambridge, MA, which is home to several top universities, teaching hospitals and a thriving biotech community of which Sanofi Genzyme is a part. This biotech funder contributes to philanthropy through in-kind donations and volunteerism with direct financial support. Its main areas of focus are Rare Diseases, Multiple Sclerosis, Immunology, and Oncology.
Sanofi Genzyme’s Contributions and Giving program supports “major initiatives in science or healthcare at nonprofits, research institutions, and global humanitarian organizations,” as well as “research fellowships, event sponsorships, community group funding, and more.” Its current disease priorities are asthma, atopic dermatitis, multiple sclerosis, oncology, rare genetic diseases, rheumatoid arthritis, and thyroid cancer. Genzyme may also consider proposals related to its parent company Sanofi’s research interests, including diabetes, renal diseases, neurobiology, cystic fibrosis, gene therapy, and biomaterials.
Sanofi Genzyme accepts applications for its charitable giving throughout the year. It reviews applications four times a year, and the entire process may take eight to sixteen weeks.
Search for staff contact info and bios in PeopleFinder (paid subscribers only).